Delivery Order SPE2DX22D0010-SPE2D825FHE16
- Not listed
- This delivery order, awarded on September 15, 2025, represents a $7,721.56 firm fixed price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This delivery order is non-set-aside and competitively awarded, with a place of performance in...
- This delivery order, awarded July 30, 2025, represents a $11,340.40 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The contract was awarded...
- This delivery order, awarded on July 28, 2025, represents a $10,330.72 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract is a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This delivery order was competitively awarded with no set-aside designation and is...
- This delivery order, awarded July 28, 2025, represents a $5,681.16 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain, a component of the Department of Defense. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order carries no set-aside designation and reflects...
- This delivery order, awarded July 26, 2025, represents a $391,359.93 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The non-competitive delivery order is set to conclude by July 28, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive...
- This delivery order, awarded on August 18, 2025, represents a $11,379.98 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This competitively awarded delivery order, with no set-aside designation, requires performance at...
- This delivery order, awarded on July 31, 2025, represents a $1,558.44 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The award was made through open...
- This delivery order, awarded on June 30, 2025, represents a $12,075.32 firm fixed price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract, which is not set-aside and was competitively awarded, is designated as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The place of performance is...
- This delivery order, awarded on September 2, 2025, represents a $1,346.22 firm fixed price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This delivery order was competitively awarded with no set-aside designation...
- This delivery order, awarded July 23, 2025, represents a $1,651.68 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside designation, indicating it was...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHE16Delivery Order
This delivery order, awarded on July 24, 2025, represents a $2,419.69 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain. The non-competitive delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, supplying a comprehensive range of pharmaceutical products and medical supplies including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's extensive federal contract portfolio demonstrates its capability to fulfill military and veteran healthcare system requirements through the DLA's Pharmaceutical Prime Vendor Global Program, which supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 7/24/25 |